Mr. Jeff Stier
Associate Director, American Council on Science and Health
Member of the Policy & Economics Council
Council Member Biography
Jeff Stier is an Associate Director at the American Council on Science and Health, a public health and consumer advocacy organization dedicated to promoting sound science in public health. In this position, he is responsible for government relations, policy, legal affairs and development. Mr. Stier specializes in food safety and nutrition (restaurant, agriculture, food and beverage industries), environmental health (chemical industry), pharmaceuticals and crisis communications regarding these industries. Additionally, he is an expert in class action litigation related to public health issues, regulatory and legal reform, tobacco policy and public health policy. Mr. Stier closely follows policies, legislations and regulations with the FDA, EPA, and USDA. He is often called upon to evaluate legal and regulatory matters related to specific health issues. Previously, Mr. Stier worked both in the office of the Mayor and in Corporation Counsel's office in the Giuliani administration in New York City. His responsibilities included planning environmental agency programs, legal analysis of proposed legislation, and health policy. His publications include “Bitter pill for FDA: law on herbal supplements,” “EPA Should Follow FDA's Bold Initiative,” “Big Tobacco Never Told the Truth,” “Drug Pipeline Gets Clamped by Jittery FDA,” “Drug Imports: A Prescription for Danger?” and “Trans Fat Ban's Economic Impact, from Fries to Soybeans.” (This is me - Update Profile)
Employment History
- 1997 - Unspecified
- Associate Director, American Council on Science and Health
GLG NewsSM Analyses by Jeff Stier(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Black Box Warnings: Not Blacklist Warnings
August 6, 2009
UPDATE: FDA: Requires Stronger Warnings For TNF Blocker Drugs | online.wsj.com
The risk highlighted by this new bold warning was a known risk. The questions are: How should physicians and patients respond to a new warning rather than new risks? What are the risks of black box warnings?What are the implications for Johnson & Johnson (JNJ), which makes Remicade and Simponi, Abbott (ABT), maker of Humira and Amgen (AMGN) and Wyeth (WYE), co-marketers of Enbrel, as well as UCB SA's (UCB.BT) maker of Cimzia?
-
FDA Warning On E-Cigs is Tone Deaf
July 22, 2009
FDA Questions Safety, Quality of Electronic Cigarettes | blogs.wsj.com
Even major tobacco companies are now considering E-cigarettes, but the FDA is dead set against them. This is a harbinger of how FDA will use their new authority to regulate tobacco.
-
Swine Flu Presents Opportunities for Vaccine Makers And Others
July 21, 2009
Financial Times FT.com | www.ft.com
A relatively small group of pharmaceutical companies includingGlaxoSmithKline, Roche and Sanofi-Aventis which make vaccines have the market cornered when it comes to the front lines of the global fight against swine flu. But well positioned smaller companies could benefit
-
Sometimes, Breast Cancer Legislation Could Do More Harm Than Good
July 14, 2009
Detecting a Bad Breast Cancer Bill | www.rollcall.com
New legislation calls for more widespread genetic testing for breast cancer as well as other types of breast cancer screening.
-
Potential Good News for Biosimilars
July 14, 2009
US Senate panel backs 12-year biotech drug shelter | www.reuters.com
This is good news for Amgen Inc (AMGN.O) and Roche Holding AG (ROG.VX) as longer exclusivity passes a major Senate hurdle. While some are calling this a defeat for "generic" (biosimilar) makers such as Teva Pharmaceutical Industries Ltd (TEVA.TA) and Mylan Inc (MYL.O), it isn't all bad news.
Leading institutions connect with Jeff Stier through GLG
GLG Study Groups with Jeff Stier(?)
| Study Group Name | No. Members |
|---|---|
| Political Experts (outside Washington DC) | 711 |
| U.S. Department of Agriculture Experts: Legal, Economic, and Regulatory Affairs | 28 |
GLG Live Meetings with Jeff Stier(?)
Jeff Stier has not participated in any GLG Live Meetings.
View all GLG Live Meetings in Legal, Economic & Regulatory Affairs